109 related articles for article (PubMed ID: 22329847)
1. ¹⁸F-FDG uptake on PET could be a predictive marker of excision repair cross-complementation group 1 (ERCC1) expression in patients with thoracic neoplasms?
Kaira K; Endo M; Shukuya T; Kenmotsu H; Naito T; Ono A; Tsuya A; Nakamua Y; Takahashi T; Murakami H; Kondo H; Nakajima T; Yamamoto N
Neoplasma; 2012; 59(3):257-63. PubMed ID: 22329847
[TBL] [Abstract][Full Text] [Related]
2. ¹⁸F-FDG uptake on PET is a predictive marker of thymidylate synthase expression in patients with thoracic neoplasms.
Kaira K; Yamamoto N; Endo M; Kenmotsu H; Naito T; Ono A; Murakami H; Ohde Y; Nakajima T; Takahashi T
Oncol Rep; 2014 Jan; 31(1):209-15. PubMed ID: 24173608
[TBL] [Abstract][Full Text] [Related]
3. Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.
Kaira K; Endo M; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Tsuya A; Nakamura Y; Naito T; Hayashi I; Serizawa M; Koh Y; Hanaoka H; Tominaga H; Oriuchi N; Kondo H; Nakajima T; Yamamoto N
J Clin Oncol; 2010 Aug; 28(23):3746-53. PubMed ID: 20625125
[TBL] [Abstract][Full Text] [Related]
4. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.
Toba H; Kondo K; Sadohara Y; Otsuka H; Morimoto M; Kajiura K; Nakagawa Y; Yoshida M; Kawakami Y; Takizawa H; Kenzaki K; Sakiyama S; Bando Y; Tangoku A
Eur J Cardiothorac Surg; 2013 Aug; 44(2):e105-12. PubMed ID: 23674658
[TBL] [Abstract][Full Text] [Related]
5. Biological correlation of ¹⁸F-FDG uptake on PET in pulmonary neuroendocrine tumors.
Kaira K; Murakami H; Endo M; Ohde Y; Naito T; Kondo H; Nakajima T; Yamamoto N; Takahashi T
Anticancer Res; 2013 Oct; 33(10):4219-28. PubMed ID: 24122985
[TBL] [Abstract][Full Text] [Related]
6. Biological significance of 18F-FDG uptake on PET in patients with non-small-cell lung cancer.
Kaira K; Serizawa M; Koh Y; Takahashi T; Yamaguchi A; Hanaoka H; Oriuchi N; Endo M; Ohde Y; Nakajima T; Yamamoto N
Lung Cancer; 2014 Feb; 83(2):197-204. PubMed ID: 24365102
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG uptake on PET in primary mediastinal non-thymic neoplasm: a clinicopathological study.
Kaira K; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Shukuya T; Kenmotsu H; Naito T; Hayashi I; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
Eur J Radiol; 2012 Sep; 81(9):2423-9. PubMed ID: 22055682
[TBL] [Abstract][Full Text] [Related]
8. Relationship between 18F-FDG uptake on positron emission tomography and molecular biology in malignant pleural mesothelioma.
Kaira K; Serizawa M; Koh Y; Takahashi T; Hanaoka H; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
Eur J Cancer; 2012 May; 48(8):1244-54. PubMed ID: 22330319
[TBL] [Abstract][Full Text] [Related]
9. Biologic correlates of ¹⁸F-FDG uptake on PET in pulmonary pleomorphic carcinoma.
Kaira K; Endo M; Abe M; Nakagawa K; Ohde Y; Okumura T; Takahashi T; Murakami H; Tsuya A; Nakamura Y; Naito T; Hayashi I; Kondo H; Nakajima T; Yamamoto N
Lung Cancer; 2011 Feb; 71(2):144-50. PubMed ID: 20646779
[TBL] [Abstract][Full Text] [Related]
10. Correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in non-small cell lung cancer.
Kaira K; Oriuchi N; Shimizu K; Ishikita T; Higuchi T; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
Cancer Sci; 2009 Apr; 100(4):753-8. PubMed ID: 19141127
[TBL] [Abstract][Full Text] [Related]
11. Expression of excision repair cross-complementation group 1, breast cancer susceptibility 1, and β III-tubulin in thymic epithelial tumors.
Kaira K; Serizawa M; Koh Y; Miura S; Kaira R; Abe M; Nakagawa K; Ohde Y; Okumura T; Naito T; Murakami H; Takahashi T; Kondo H; Nakajima T; Endo M; Yamamoto N
J Thorac Oncol; 2011 Mar; 6(3):606-13. PubMed ID: 21289518
[TBL] [Abstract][Full Text] [Related]
12. Correlation between 18F-FDG uptake on PET and molecular biology in metastatic pulmonary tumors.
Kaira K; Okumura T; Ohde Y; Takahashi T; Murakami H; Oriuchi N; Endo M; Kondo H; Nakajima T; Yamamoto N
J Nucl Med; 2011 May; 52(5):705-11. PubMed ID: 21498541
[TBL] [Abstract][Full Text] [Related]
13. ¹⁸FDG PET for grading malignancy in thymic epithelial tumors: significant differences in ¹⁸FDG uptake and expression of glucose transporter-1 and hexokinase II between low and high-risk tumors: preliminary study.
Nakajo M; Kajiya Y; Tani A; Yoneda S; Shirahama H; Higashi M; Nakajo M
Eur J Radiol; 2012 Jan; 81(1):146-51. PubMed ID: 20810231
[TBL] [Abstract][Full Text] [Related]
14. [18F]Fluorodeoxyglucose PET in Thoracic Malignancies.
Vilstrup MH; Torigian DA
PET Clin; 2014 Oct; 9(4):391-420, v. PubMed ID: 26050944
[TBL] [Abstract][Full Text] [Related]
15. [Correlation between SUV of (18)F-FDG PET-CT and the expression of GLUT1, MVD and Ki67 in non-small cell lung cancer].
Duan Y; Yu LJ; Lu PO; Wang WZ
Zhonghua Zhong Liu Za Zhi; 2008 Oct; 30(10):764-7. PubMed ID: 19173807
[TBL] [Abstract][Full Text] [Related]
16. PET: other thoracic malignancies.
Quint LE
Cancer Imaging; 2006 Oct; 6(Spec No A):S82-8. PubMed ID: 17114082
[TBL] [Abstract][Full Text] [Related]
17. The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.
Fukumoto K; Taniguchi T; Ishikawa Y; Kawaguchi K; Fukui T; Kato K; Matsuo K; Yokoi K
Eur J Cardiothorac Surg; 2012 Dec; 42(6):e152-6. PubMed ID: 23024234
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of [18F]fluoro-2-deoxy-D-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors.
Igai H; Matsuura N; Tarumi S; Chang SS; Misaki N; Go T; Ishikawa S; Yokomise H
Eur J Cardiothorac Surg; 2011 Jul; 40(1):143-5. PubMed ID: 20951602
[TBL] [Abstract][Full Text] [Related]
19. The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors.
Kaira K; Sunaga N; Ishizuka T; Shimizu K; Yamamoto N
Cancer Imaging; 2011 Nov; 11(1):195-201. PubMed ID: 22138614
[TBL] [Abstract][Full Text] [Related]
20. Tumor immunity is related to
Imai H; Kaira K; Hashimoto K; Nitanda H; Taguchi R; Yanagihara A; Umesaki T; Yamaguchi O; Mouri A; Kawasaki T; Yasuda M; Kobayashi K; Sakaguchi H; Kuji I; Kagamu H
Cancer Med; 2021 Sep; 10(18):6317-6326. PubMed ID: 34363337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
